Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
You have these already downloaded
We have sent you a copy of the report to your email again.
Tata Consultancy Services’ End-To-End Offering for Decentralized Trials, TCS ADD™ Connected Clinical Trials Cited as a Key Strength
NEW YORK | MUMBAI, October 25, 2022: Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) has been named a Leader in the IDC MarketScape for Worldwide Life Science R&D Decentralized Clinical Trial (DCT) Technology Solutions[1].
According to the report, “TCS' differentiators include the breadth of DCT capabilities that it offers, the ease of implementation of its solutions, and its competitive pricing. Its value proposition for DCTs is its end-to-end integrated platform and its ecosystem play.”
“The momentum towards adoption of digitalization of clinical trials has really accelerated in the past few years. We had however envisioned the shift towards decentralization in the clinical trials space early on and architected our solution accordingly. Consequently, when the pandemic hit, our customers were equipped to run studies leveraging our ready-to-use offerings such as eConsenting, Supply Management, smart medication management, BYOD configured patient and site app,” said Rachna Malik, Global Head, TCS ADD™ platforms. “We believe our position as a Leader in the evaluation of DCT providers validates the rectitude in our vision, investment in intellectual property and resulting market success.”
TCS ADD Connected Clinical Trials is a comprehensive suite of AI/ML-based platforms for decentralized trials. It provides a unified interface for patients and sites, facilitates collaboration with stakeholders such as regulators, sites, and health authorities, and enables patient-centric trials. The platform connects patients, sites, and sponsors through a variety of innovative sensors, smart medication packages, and mobile devices, to enhance trial outcomes. It caters to operations across the clinical studies lifecycle including e-consent, smart questionnaire (eCOA, diaries and surveys), an industry first supply management platform that brings together kit tracking, digital labels, and unit/dose tracking (medication adherence), and telemedicine.
The platform is comprehensive, interoperable and supports eco-system interplay, has multilingual capabilities, as well as the ability to be hosted on multi-cloud and multi-region. In addition, TCS ADD Connected Clinical Trials supports automated data collection, enables remote monitoring and oversight suitable for high frequency and a high volume of data.
“The DCT landscape is an ever-evolving ecosystem play, including a multitude of players bringing together a wide spectrum of innovative technologies. The secret sauce for scaling success will lie in integrating the right mix of partners and technologies, harmonizing workflows and dataflows, and building ‘digital-first’ strategies to provide patients and sites with an enriched, frictionless experience, while ensuring compliance at all costs,” said Dr Nimita Limaye, Research VP, Life Sciences R&D Strategy & Technology, IDC. “The TCS ADD suite of modern and open platforms, and TCS’ ability to drive cross-industry collaborations and expertise in technology implementation have made it a Leader in this report.”
TCS ADD™ is a suite of modern and open drug development platform for life sciences that enables digital ecosystems, simplifies data complexity and provides faster access to new and effective drugs for patients in need. The platform is powered by our proprietary cognitive artificial intelligence engine, data driven smart analytics and Internet of Things (IoT) that makes clinical trials more agile and safe. TCS ADD leverages the best of cloud architecture and personalized user experience design in compliance with quality guidelines and privacy regulations.
To know more visit www.tcs.com/tcs-add or email: add.platform@tcs.com
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
corporate.communications@tcs.com
saxena.kritika@tcs.com
+91 22 6778 9999
vanshika.sood@tcs.com
+91 22 67789098
y.tham@tcs.com
+65 9720 9005
tiffany.fisher@tcs.com
+1 416 456 7650
alma.leal@tcs.com
+521 55 2095 6098
kelly.ryan@tcs.com
+61 422 989 682
joost.galema@tcs.com
+31 615 903387
douglas.foote@tcs.com
+81 80 2115 0989
pragya.priyadarshini@tcs.com
+971 528656700
t.doherty@tcs.com
+44(0)7759396160
james.sciales@tcs.com
+1 917 981 7651
TCS Awarded India’s Best Employer Brand by LinkedIn
TCS Partners With IIT KGP to Launch Advanced Research Center for Innovation in Digital Health, Robotics & Intelligent Systems
TCS Expands Partnership with SPARSH, India’s Pension System for Defence Personnel, by Three Years
TCS Signs Multi-Year Deal with Air France-KLM to Accelerate Data-Driven Aviation